Editorial: Cytochromes P450, their modulators and metabolites in cardiovascular function and disease

Adeniyi M Adebesin; Richard Joseph Roman; William B Campbell; John M Seubert; Rheem A Totah

doi:10.3389/fphar.2024.1531166

Editorial: Cytochromes P450, their modulators and metabolites in cardiovascular function and disease

Front Pharmacol. 2024 Dec 3:15:1531166. doi: 10.3389/fphar.2024.1531166. eCollection 2024.

Authors

Adeniyi M Adebesin¹, Richard Joseph Roman², William B Campbell³, John M Seubert⁴, Rheem A Totah⁵

Affiliations

¹ Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, TX, United States.
² Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, MS, United States.
³ Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, WI, United States.
⁴ Department of Pharmacology, Faculty of Pharmacy/Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada.
⁵ Department of Medicinal Chemistry, University of Washington, Seattle, WA, United States.

No abstract available

Keywords: antihypertensive active components; cardiac hypertrophy; cardiovascular diseases (CVD); cytochromes P450; epoxyeicosatrienoic acid (EETs); hydroxyeicosatetraenoic acid (HETE); soluble epoxide hydrolase (sEH).

Publication types

Editorial

Grants and funding

The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.